AGP Executive Report
Last update: 7 hours agoSurrogacy & maternal care: Texas AG Ken Paxton pushed for “life-saving care” for “Baby Gabriel” in a Dallas parentage/abortion dispute, renewing scrutiny of how state law can delay treatment for treatable conditions. Hospital billing pressure: Hospitals are increasingly moving toward upfront payment requirements as costs rise, shifting more financial risk to patients before care. Drug safety & fraud: Eli Lilly sued six companies over alleged illegal sales of experimental weight-loss drug retatrutide, targeting compounding pharmacies, med spas, and online sellers selling to consumers despite no FDA approval. Texas THC crackdown: Texas banned several hemp-derived THC products (including delta-8 and delta-10), while delta-9 THC remains legal—another shake-up for the state’s hemp market. Public health & access: Abortion laws in Texas are disrupting maternal care, with reported delays turning pregnancy complications into life-threatening crises. Infectious disease watch: Dallas County reported its first human case of West Nile virus. Healthcare workforce & tech: A new consortium of 12 hospital systems aims to speed and improve diagnostic AI workflows, especially in radiology.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
